uric acid and hp 228

uric acid has been researched along with hp 228 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
D'Amico, M; Di Filippo, C; Getting, SJ; Perretti, M	1

Other Studies

1 other study(ies) available for uric acid and hp 228

Article	Year
The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage. European journal of pharmacology, 2006, Feb-17, Volume: 532, Issue:1-2 Topics: Acute Disease; alpha-MSH; Animals; Anti-Inflammatory Agents; Blood Pressure; Carrageenan; Chemokine CXCL1; Chemokines; Chemokines, CXC; Cyclic AMP; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Inflammation; Interleukin-1; Macrophages, Peritoneal; Male; Mice; Myocardial Reperfusion Injury; Oligopeptides; Peritonitis; Time Factors; Tumor Necrosis Factor-alpha; Uric Acid; Zymosan	2006

Article

Year

The melanocortin peptide HP228 displays protective effects in acute models of inflammation and organ damage.

European journal of pharmacology, 2006, Feb-17, Volume: 532, Issue:1-2

Topics: Acute Disease; alpha-MSH; Animals; Anti-Inflammatory Agents; Blood Pressure; Carrageenan; Chemokine CXCL1; Chemokines; Chemokines, CXC; Cyclic AMP; Cytokines; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Rate; Inflammation; Interleukin-1; Macrophages, Peritoneal; Male; Mice; Myocardial Reperfusion Injury; Oligopeptides; Peritonitis; Time Factors; Tumor Necrosis Factor-alpha; Uric Acid; Zymosan

2006